CAS 1346599-35-6

Formule : C21H26ClN5O

InChI : InChI=1S/C21H26ClN5O/c1-2-17-7-8-18(16-19(17)22)25-14-12-24(13-15-25)9-5-11-27-21(28)26-10-4-3-6-20(26)23-27/h3-4,6-8,10,16H,2,5,9,11-15H2,1H3

Code InChI : FAKVJGFSBCIPNY-UHFFFAOYSA-N

SMILES : CCC1=C(C=C(C=C1)N2CCN(CC2)CCCN3C(=O)N4C=CC=CC4=N3)Cl

Trazodone EP Impurity E (Trazodone Hydrochloride BP Impurity E)

CAS : 1346599-35-6

Formule : C₂₁H₂₆ClN₅O

Couleur et forme : White To Off-White Solid

Masse moléculaire : 399.92

Ref: 4Z-T-337

Ethyl Trazodone

CAS : 1346599-35-6

Degré de pureté : 98%

Ref: IN-DA01E1A2

Trazodone EP Impurity E

CAS : 1346599-35-6

Formule : C₂₁H₂₆ClN₅O

Masse moléculaire : 399.92

Ref: ST-EA-CP-T29005

Ethyl Trazodone

Produit contrôlé

CAS : 1346599-35-6

Formule : C₂₁H₂₆ClN₅O

Couleur et forme : Neat

Masse moléculaire : 399.92

Ref: TR-E927100

2-[3-[4-(3-Chloro-4-ethylphenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one

CAS : 1346599-35-6

2-[3-[4-(3-Chloro-4-ethylphenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one is a research and development impurity standard. Impurities are the substances that are not intentionally added to the drug product but can be generated from the synthesis process or from the raw materials. This substance has been used as a synthetic intermediate in the production of other drugs and as an analytical reference for HPLC analysis. It is used to help develop new drugs by providing data about metabolites and possible toxic effects on humans.

Degré de pureté : Min. 95%

Ref: 3D-IC171026